Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway

Huangkui Capsule in Combination with Leflunomide Improves Immunoglobulin A Nephropathy by Inhibiting the TGF-β1/Smad3 Signaling Pathway

OBJECTIVES: To investigate the efficacy and potential molecular mechanism of Huangkui capsule in combination with leflunomide (HKL) for the treatment of immunoglobulin A nephropathy (IgAN) METHODS: IgAN rat models were constructed by treating rats with bovine serum albumin, lipopolysaccharide, and...

Full description

Bibliographic Details
Main Authors:	Shuwen Pei, Yan Li
Format:	Article
Language:	English
Published:	Elsevier España 2021-12-01
Series:	Clinics
Subjects:	IgA Nephropathy Huangkui Capsules Leflunomide Th22 Cells TGF-β1/Smad3 Signaling Pathway
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322021000100348&tlng=en

Similar Items

Efficacy and safety of low-dose corticosteroids combined with leflunomide for progressive IgA nephropathy: a systematic review and meta-analysis
by: Dongxu Zhang, et al.
Published: (2024-03-01)

Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy
by: Yebei Li, et al.
Published: (2021-11-01)

Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial
by: Zhaohui Ni, et al.
Published: (2021-01-01)

The Anti-Rheumatic Drug, Leflunomide, Induces Nephrotoxicity in Mice via Upregulation of TGFβ-Mediated p53/Smad2/3 Signaling
by: Alhanouf A. Aljohani, et al.
Published: (2022-05-01)

Evaluation of the efficacy of Abelmoschus manihot (L.) on diabetic nephropathy by analyzing biomarkers in the glomeruli and proximal and distal convoluted tubules of the kidneys
by: Hongmei Yu, et al.
Published: (2023-08-01)

Retrospective analysis of leflunomide and low-dose methylprednisolone for the treatment of diabetic nephropathy combined with membranous nephropathy
by: Shunlai Shang, et al.
Published: (2022-08-01)

The Outcome of Childhood Immunoglobulin A Nephropathy with Acute Kidney Injury at the Onset of the Disease—National Study
by: M. Mizerska-Wasiak, et al.
Published: (2023-10-01)

TGF-Beta as a Master Regulator of Diabetic Nephropathy
by: Li Wang, et al.
Published: (2021-07-01)

An Update on the Current State of Management and Clinical Trials for IgA Nephropathy
by: Chee Kay Cheung, et al.
Published: (2021-06-01)

Clinical manifestations and pathological correlation of immunoglobulin A nephropathy in children
by: Karnchanit Sausukpaiboon, et al.
Published: (2022-11-01)

Recurrent Immunoglobulin A Nephropathy after Kidney Transplant—An Updated Review
by: Hwarang S. Han, et al.
Published: (2023-09-01)

History of IgA Nephropathy Mouse Models
by: Batoul Wehbi, et al.
Published: (2021-07-01)

Huangkui lianchang decoction attenuates experimental colitis by inhibiting the NF-κB pathway and autophagy
by: Xudong Cheng, et al.
Published: (2022-08-01)

Glomerular Galactose-Deficient IgA1(KM55) Positive May Predict Poorer Prognosis in Coexisting Primary Membranous Nephropathy and IgA Nephropathy Patients
by: Wenrong Cheng, et al.
Published: (2022-12-01)

Evaluation of leflunomide for the treatment of BK viremia and biopsy proven BK nephropathy; a single center experience
by: Nicole Nesselhauf, et al.
Published: (2016-01-01)

Current understanding of IgA antibodies in the pathogenesis of IgA nephropathy
by: Yoshihito Nihei, et al.
Published: (2023-04-01)

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy
by: Jin Sug Kim, et al.
Published: (2020-11-01)

IgA Nephropathy Associated with IgA Vasculitis Coexisting with Focal Segmental Glomerulosclerosis Tip Variant
by: Zitlali Guadalupe Paulín Zepeda, et al.
Published: (2023-07-01)

IgA Vasculitis and IgA Nephropathy: Same Disease?
by: Evangeline Pillebout
Published: (2021-05-01)

Use of low-dose sulodexide in IgA nephropathy patients on renin–angiotensin system blockades
by: Byeong Yun Yang, et al.
Published: (2012-09-01)

An Update on Current Therapeutic Options in IgA Nephropathy
by: Regina Shaoying Lim, et al.
Published: (2024-02-01)

The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy
by: Liping Sun, et al.
Published: (2023-03-01)

The Effect of Hydroxychloroquine on Residual Proteinuria in Patients With Immunoglobulin A Nephropathy: A Retrospective Study Based on Propensity Score Matching
by: Mijia Liu, et al.
Published: (2022-07-01)

TGF-β/Smad Signalling in Neurogenesis: Implications for Neuropsychiatric Diseases
by: Lih-Fhung Hiew, et al.
Published: (2021-06-01)

Regulation of TGF-β Superfamily Signaling by SMAD Mono-Ubiquitination
by: Feng Xie, et al.
Published: (2014-10-01)

Aberrantly Glycosylated IgA1 in IgA Nephropathy: What We Know and What We Don’t Know
by: Yukako Ohyama, et al.
Published: (2021-08-01)

Present and Future of IgA Nephropathy and Membranous Nephropathy Immune Monitoring: Insights from Molecular Studies
by: Francesca Zanoni, et al.
Published: (2023-08-01)

Effect of echinacoside on kidney fibrosis by inhibition of TGF-β1/Smads signaling pathway in the db/db mice model of diabetic nephropathy
by: Tang FJ, et al.
Published: (2017-09-01)

Mitofusin2 expression is associated with podocyte injury in IgA nephropathy
by: Xuanli Tang, et al.
Published: (2023-03-01)

Gut Microbes in Immunoglobulin A Nephropathy and Their Potential Therapeutic Applications
by: Yi Wang, et al.
Published: (2022-05-01)

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy
by: Yusuke Fukao, et al.
Published: (2022-06-01)

Current knowledge of targeted-release budesonide in immunoglobulin A nephropathy: A comprehensive review
by: Jian Liao, et al.
Published: (2023-01-01)

Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
by: Renato C. Monteiro, et al.
Published: (2022-03-01)

Diabetes mellitus with a duration of 26 years combined with IgA nephropathy: A case report and literature review
by: Yan-Li Gou, et al.
Published: (2022-12-01)

Comparative study on clinicopathological features and prognosis of IgA vasculitis nephritis and IgA nephropathy in children
by: Yan Lv, et al.
Published: (2023-08-01)

Nomogram for the prediction of crescent formation in IgA nephropathy patients: a retrospective study
by: Zaoqiang Lin, et al.
Published: (2023-09-01)

Efficacy and safety of sequential immunosuppressive treatment for severe IgA nephropathy: A retrospective study
by: Mian-Na Luo, et al.
Published: (2023-03-01)

Role of telitacicept in the treatment of IgA nephropathy
by: Lijun Wu, et al.
Published: (2023-09-01)

Management of IgA Nephropathy in Pediatric Patients
by: Sophie Schroda, et al.
Published: (2022-05-01)

Concurrent IgA Nephropathy and Membranous Nephropathy, Is It an Overlap Syndrome?
by: Jia-Wei He, et al.
Published: (2022-03-01)